“Efficacy and Safety of Tralokinumab in US Adults With Moderate-to-Severe Atopic Dermatitis: A Post-Hoc Analysis of ECZTRA3”. 2023. SKIN The Journal of Cutaneous Medicine 7 (2): 686-95. https://doi.org/10.25251/skin.7.2.5.